Right ventricular hypertrophy is the result of compensatory increased resistance to pulmonary arterial flow as the basis for your response to mr. garabedian.
<h3>What is right ventricular hypertrophy?</h3>
- The condition known as right ventricular hypertrophy (RVH), which is most frequently caused by severe lung illness, is an abnormal enlargement or pathologic increase in the right ventricle's muscle mass in response to pressure overload.
- It can cause major problems, such as cardiac failure, if left untreated.
- Call your doctor right away if you get any heart-related symptoms, such as chest pain, breathlessness, or swelling in your legs.
- Treatment options for hypertrophic cardiomyopathy-related left ventricular hypertrophy include medication, a nonsurgical technique, surgery, implanted devices, and dietary and lifestyle modifications.
- Medication, chemotherapy, and even a stem cell transplant are all part of the amyloidosis treatment strategy.
- Severe pulmonary illness is the most frequent cause of right ventricular hypertrophy.
- The following conditions are among those that cause secondary right ventricular hypertrophy and pulmonary hypertension.
- Arterial hypertension in the lungs (PAH) lung hypertension brought on by left heart disease.
Learn more about right ventricular hypertrophy here:
brainly.com/question/13063959
#SPJ4
Answer:
b) blastic red blood cell (RBC).
Explanation:
In excess of 340 blood group antigens have now been described that vary between individuals. Thus, any unit of blood that is nonautologous represents a significant dose of alloantigen. Most blood group antigens are proteins, which differ by a single amino acid between donors and recipients. Approximately 1 out of every 70 individuals are transfused each year (in the United States alone), which leads to antibody responses to red blood cell <u>(RBC) alloantigens</u> in some transfusion recipients. When alloantibodies are formed, in many cases, RBCs expressing the antigen in question can no longer be safely transfused. However, despite chronic transfusion, only 3% to 10% of recipients (in general) mount an alloantibody response. In some disease states, rates of alloimmunization are much higher (eg, sickle cell disease). For patients who become alloimmunized to multiple antigens, ongoing transfusion therapy becomes increasingly difficult or, in some cases, impossible. While alloantibodies are the ultimate immune effector of humoral alloimmunization, the cellular underpinnings of the immune system that lead to ultimate alloantibody production are complex, including antigen consumption, antigen processing, antigen presentation, T-cell biology.
Answer:
The Living Will
Explanation: Living Will is a document giving directives to the care givers and physicians on how and when to withdraw medical supports to patients with terminally illness or withhold artificial supports.
It can only be used if the person will not be able to give the instructions himself,without this document the doctor is legally and ethical bound to keep the terminally patient alive till the Document is fully signed.The living will help the terminally ill person and his or her relatives to know about what is to be administered on the person.
The term myalgia denotes pain in a muscle. Hope this helps!
Answer:
You have just given 2.5 tablet(s) with a dosage strength of 10 mg each. What was the total dosage administered? 30 mg
